Panax-derived ginsenosides in diabetes-associated cognitive dysfunction: mechanistic evidence and translational barriers.

Yong Q, Zhao X, Xu Y, Bai H, Ye H

Open source

DOI
10.3389/fendo.2026.1965933
Published
2026
Container
Frontiers in endocrinology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1965933,
  title = {Panax-derived ginsenosides in diabetes-associated cognitive dysfunction: mechanistic evidence and translational barriers.},
  author = {Yong Q and Zhao X and Xu Y and Bai H and Ye H},
  year = {2026},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2026.1965933},
  url = {https://doi.org/10.3389/fendo.2026.1965933}
}

RIS

TY  - JOUR
TI  - Panax-derived ginsenosides in diabetes-associated cognitive dysfunction: mechanistic evidence and translational barriers.
AU  - Yong Q
AU  - Zhao X
AU  - Xu Y
AU  - Bai H
AU  - Ye H
PY  - 2026
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2026.1965933
UR  - https://doi.org/10.3389/fendo.2026.1965933
ER  - 

APA

Q, Y., X, Z., Y, X., H, B., & H, Y. (2026). Panax-derived ginsenosides in diabetes-associated cognitive dysfunction: mechanistic evidence and translational barriers.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1965933

Source records